On being metachromatic: Mystique and misunderstanding in mastocytosis

Authors

  • Jason Gotlib

    Corresponding author
    1. Department of Medicine, Division of Hematology, Stanford University School of Medicine/Stanford Cancer Center, Stanford, CA
    • Stanford Cancer Center, 875 Blake Wilbur Drive, Room 2324, Stanford, CA 94305-5821
    Search for more papers by this author

  • Conflict of interest: J.G. receives research funding from Novartis, Inc., for an investigator-initiated trial of midostaurin (PKC412) in patients with advanced mastocytosis, and serves as Steering Committee Chairman for a Novartis-sponsored trial of midostaurin in the same patient population.

No abstract is available for this article.

Ancillary